We are live on ! Find out more
AL

Aspiriant LLC Portfolio holdings

AUM $4.05B
1-Year Est. Return 19.01%
This Fund
S&P 500
This Quarter Est. Return
+5.8%
1 Year Est. Return
+19.01%
3 Year Est. Return
+47.13%
5 Year Est. Return
+48.95%
10 Year Est. Return
+147.53%
AUM
$1.87B
AUM Growth
+$168M
Cap. Flow
+$75.3M
Cap. Flow %
4.03%
Top 10 Hldgs %
59.38%
Holding
286
New
54
Increased
143
Reduced
45
Closed
6

Sector Composition

Rank Sector Weight
1 Technology 10.2%
2 Financials 2.57%
3 Communication Services 2.19%
4 Healthcare 1.2%
5 Consumer Discretionary 0.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RSP icon
276
Invesco S&P 500 Equal Weight ETF
RSP
$97.3B
$201K 0.01%
+1,237
New +$195K
MRO
277
DELISTED
Marathon Oil Corporation
MRO
$198K 0.01%
12,109
+889
+8% +$14.3K
IGR
278
CBRE Global Real Estate Income Fund
IGR
$719M
$154K 0.01%
+15,775
New +$144K
NOK icon
279
Nokia
NOK
$47.2B
$129K 0.01%
20,830
CANG
280
Cango Inc
CANG
$64.4M
$38K ﹤0.01%
+1,200
New +$45.5K
SLNO
281
DELISTED
Soleno Therapeutics
SLNO
$7K ﹤0.01%
1,153
ITIC
282
Investors Title Co
ITIC
$559M
-7,185
Closed -$1.31M
RWX icon
283
State Street SPDR Dow Jones International Real Estate ETF
RWX
$269M
-26,189
Closed -$930K
SCHF icon
284
Schwab International Equity ETF
SCHF
$65.2B
-10,482
Closed -$203K
XME icon
285
State Street SPDR S&P Metals & Mining ETF
XME
$3.75B
-10,063
Closed -$420K
XRT icon
286
State Street SPDR S&P Retail ETF
XRT
$458M
-6,181
Closed -$558K

Similar funds

Aspiriant LLC's Q4 2021 Portfolio in Review

As of Q4 2021, Aspiriant LLC held 286 positions worth $1.87B, up 9.9% from $1.7B the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Aspiriant LLC deployed $75.3M of net new capital in Q4 2021, opening 54 new positions and adding to 143 existing holdings. Its largest new stake was Leidos: 135,400 shares worth $12M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 8.8% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was Vanguard Small-Cap Value ETF, an estimated $8.47M trimmed.

  • Aspiriant LLC's largest Q4 2021 buy was Leidos: 135,400 shares worth $12M.
  • Aspiriant LLC added most to iShares Core S&P Mid-Cap ETF in Q4 2021, an estimated $6.85M increase.
  • Aspiriant LLC's biggest Q4 2021 reduction was Vanguard Small-Cap Value ETF, cutting an estimated $8.47M.
  • Aspiriant LLC fully exited Investors Title Co in Q4 2021, selling an estimated $1.31M.
  • Aspiriant LLC's ten largest holdings make up 59% of its $1.87B portfolio in Q4 2021.
  • Aspiriant LLC opened 54 new positions and closed 6 in Q4 2021.
  • Aspiriant LLC's portfolio value rose 9.9% quarter-over-quarter to $1.87B.

Based on Aspiriant LLC's 13F filing for Q4 2021, filed 14 Feb 2022.